Skip to main content

Advertisement

Log in

Complete remission of primary membranous nephropathy following hepatitis E infection

  • Case Report
  • Published:
CEN Case Reports Aims and scope Submit manuscript

Abstract

Primary membranous nephropathy (PMN) is a major cause of nephrotic syndrome in adults. Studies have shown that one-third of PMN cases undergo spontaneous remission, among which are some cases of infection-related complete remission. Herein, we report the case of a 57-year-old man who achieved complete remission of PMN shortly after the onset of acute hepatitis E infection. At the age of 55 years, the patient developed a nephrotic syndrome, and renal biopsy revealed membranous nephropathy, Ehrenreich-Churg stage 1. Treatment with prednisolone (PSL) reduced urinary protein from 7.8 g/gCre to approximately 1 g/gCre but did not lead to complete remission. However, 7 months after starting treatment, he developed an acute hepatitis E infection after consuming wild boar meat. Immediately after the onset of acute hepatitis E, the patient’s urinary protein levels decreased to < 0.3 g/gCre. The PSL dose was subsequently reduced and discontinued after 2 years and 8 months, and complete remission was maintained thereafter. We considered that an increase in the number of regulatory T cells (Tregs) caused by acute hepatitis E infection was associated with PMN remission in this patient.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Sethi S. New ‘Antigens’ in membranous nephropathy. J Am Soc Nephrol. 2021;32:268–78.

    Article  CAS  PubMed  Google Scholar 

  2. Lerner GB, Virmani S, Henderson JM, Francis JM, Beck LH. A conceptual framework linking immunology, pathology, and clinical features in primary membranous nephropathy. Kidney Int. 2021;100:289–300.

    Article  CAS  PubMed  Google Scholar 

  3. Ye W, Wang Y, Wen Y, Li H, Li X. Dramatic remission of nephrotic syndrome after unusual complication of mucormycosis in idiopathic membranous nephropathy. Int Urol Nephrol. 2014;46:1247–51.

    Article  PubMed  Google Scholar 

  4. Wen YK, Chen ML. Remission of nephrotic membranous glomerulonephritis after high-dose trimethoprim-sulfamethoxazole treatment for pneumocystis jiroveci pneumonia. Clin Nephrol. 2007;68:99–103.

    Article  CAS  PubMed  Google Scholar 

  5. Tripathy AS, Das R, Rathod SB, Gurav YK, Arankalle VA. Peripheral T regulatory cells and cytokines in hepatitis E infection. Eur J Clin Microbiol Infect Dis. 2012;31:179–84.

    Article  CAS  PubMed  Google Scholar 

  6. Wang YM, Zhang GY, Hu M, Polhill T, Sawyer A, Zhou JJ, Saito M, Watson D, Wu H, Wang Y, Wang XM, Wang Y, Harris DCH, Alexander SI. CD8+ regulatory T cells induced by T cell vaccination protect against autoimmune nephritis. J Am Soc Nephrol. 2012;23:1058–67.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Rosenzwajg M, Languille E, Debiec H, Hygino J, Dahan K, Simon T, Klatzmann D, Ronco P. B- and T-cell subpopulations in patients with severe idiopathic membranous nephropathy may predict an early response to rituximab. Kidney Int. 2017;92:227–37.

    Article  CAS  PubMed  Google Scholar 

  8. Ramachandran R, Kaundal U, Girimaji N, Rakha A, Rathi M, Gupta KL, Kohli HS, Jha V. Regulatory B cells are reduced and correlate with disease activity in primary membranous nephropathy. Kidney Int Rep. 2020;5:872–8.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Horvatits T, Schulze Zur Wiesch J, Lütgehetmann M, Lohse AW, Pischke S. The clinical perspective on hepatitis E. Viruses. 2019;11:617.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Nimgaonkar I, Ding Q, Schwartz RE, Ploss A. Hepatitis E virus: advances and challenges. Nat Rev Gastroenterol Hepatol. 2018;15:96–110.

    Article  PubMed  Google Scholar 

  11. Kamar N, Izopet J, Pavio N, Aggarwal R, Labrique A, Wedemeyer H, Dalton HR. Hepatitis E virus infection. Nat Rev Dis Primers. 2017;3:17086.

    Article  PubMed  Google Scholar 

  12. Takahashi M, Kusakai S, Mizuo H, Suzuki K, Fujimura K, Masuko K, Sugai Y, Aikawa T, Nishizawa T, Okamoto H. Simultaneous detection of immunoglobulin A (IgA) and IgM antibodies against hepatitis E virus (HEV) is highly specific for diagnosis of acute HEV infection. J Clin Microbiol. 2005;43:49–56.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Kamar N, Weclawiak H, Guilbeau-Frugier C, Legrand-Abravanel F, Cointault O, Ribes D, Esposito L, Cardeau-Desangles I, Guitard J, Sallusto F, Muscari F, Peron JM, Alric L, Izopet J, Rostaing L. Hepatitis E virus and the kidney in solid-organ transplant patients. Transplantation. 2012;93:617–23.

    Article  PubMed  Google Scholar 

  14. Taton B, Moreau K, Lepreux S, Bachelet T, Trimoulet P, De Ledinghen V, Pommereau A, Ronco P, Kamar N, Merville P, Couzi L. Hepatitis E virus infection as a new probable cause of de novo membranous nephropathy after kidney transplantation. Transpl Infect Dis. 2013;15:E211–5.

    Article  CAS  PubMed  Google Scholar 

  15. Dominguez-Villar M, Hafler DA. Regulatory T cells in autoimmune disease. Nat Immunol. 2018;19:665–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. McTernan PM, Levitt DE, Welsh DA, Simon L, Siggins RW, MolinaPE. Alcohol impairs immunometabolism and promotes naïve T cell differentiation to pro-inflammatory Th1 CD4+ T cells. Front Immunol. 2022. https://doi.org/10.3389/fimmu.2022.839390.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We would like to thank Editage (www.editage.com) for English language editing.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Akashi Togawa.

Ethics declarations

Conflict of interest

All the authors have declared no competing interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee at which the studies were conducted (Shizuoka Saiseikai General Hospital, IRB approval number 4-13-01) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Takanohashi, S., Sugiura, T., Koyano, A. et al. Complete remission of primary membranous nephropathy following hepatitis E infection. CEN Case Rep 12, 384–389 (2023). https://doi.org/10.1007/s13730-023-00780-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13730-023-00780-z

Keywords

Navigation